Recursion Appoints Vicki Goodman as Chief Medical Officer
Recursion Pharmaceuticals (RXRX) announced that Vicki Goodman will become Recursion's chief medical officer effective April 6 as David Mauro transitions out of the role. Previously, she was executive VP, product development and medical affairs and chief medical officer at Exelixis (EXEL).